Pyxis Oncology
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $16,146 |
Gross Profit | 0 | 0 | -585 | 14,555 |
EBITDA | -18,555 | -23,023 | -20,032 | -4,489 |
EBIT | -19,105 | -23,754 | -20,617 | -5,605 |
Net Income | -35,571 | -21,203 | -17,301 | -3,256 |
Net Change In Cash | 0 | 0 | 0 | 16,146 |
Free Cash Flow | -19,290 | -14,665 | -2,945 | -20,947 |
Cash | 19,473 | 12,056 | 25,074 | 29,439 |
Basic Shares | 60,715 | 60,715 | 60,495 | 51,289 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $16,146 | $0 | $0 | $0 |
Gross Profit | 15,671 | -2,000 | -1,836 | -1,251 |
EBITDA | -65,514 | -78,493 | -122,772 | -69,070 |
EBIT | -68,496 | -80,493 | -123,481 | -70,321 |
Net Income | -77,331 | -73,790 | -117,953 | -81,536 |
Net Change In Cash | 16,146 | 0 | 0 | 0 |
Cost of Revenue | -95,551 | 268,128 | ||
Free Cash Flow | -57,909 | -77,435 | -95,734 | -35,866 |
Cash | 19,473 | 9,664 | 179,293 | 274,735 |
Basic Shares | 58,445 | 39,904 | 33,033 | 32,222 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.26 |
2024-09-30 | -$0.35 |
2024-06-30 | -$0.29 |
2024-03-31 | -$0.06 |
